Ranitidine
Product Images NDC 41163-353

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 41163-353). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Supervalu Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

This Is The 30 Count Blister Carton Label For Equaline Ranitidine Tablets, 75 mg. (Image 01)

Equaline acid reducer ranitidine tablets USP 75 mg tablet packaging label. The label highlights it contains 30 tablets and compares the active ingredient to Zantac 75. The packaging also features marketing text stating it prevents and relieves heartburn associated with acid indigestion and sour stomach. The labeler is not explicitly shown on this part of the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.